The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
The Tass Lab has invented non-invasive, Vibrotactile Coordinated Reset (vCR) stimulation devices and methods to safely and efficiently treat brain disorders characterized by abnormal neuronal synchrony such as Parkinson's disease.
Stanford researchers have developed a strategy for secondary wastewater treatment using a membrane-aerated biofilm reactor (MABR) design that enables the simultaneous removal of pollutants and recovery of potent greenhouse gas (N2O) emissions.
Stanford inventors have developed a mobile thermoelectric device designed to preserve organs during transit by maintaining 10°C (+/-1°C) for over 6 hours.
Researchers at Stanford have developed a nanoparticle-based platform to enhance activation of self-specific CD8+ T cells in the tumor microenvironment to fight cancer while minimizing toxic side effects.
Stanford researchers within the Dionne Lab have developed a method to use copper titanium dioxide core-shell nanoparticles for the light driven production of green fuels or removal of contaminants in water.
Stanford inventors have developed a nanoparticle containing the toll-like receptor agonist (TLR7-NP) that elicits a potent anti-tumor immune response in multiple cancer types without inducing undesired systemic inflammation and toxicity.
Researchers at Stanford have developed practical applications that use germline information (e.g., germline epitope burden) for diagnosis, monitoring and treatment of cancer.